Navigation Links
Gilead Sciences Supports HarborPath's HIV/AIDS Medication Assistance Pilot Program
Date:4/24/2013

COLUMBIA, S.C., April 24, 2013 /PRNewswire/ -- HarborPath, an organization which provides a single point of access to HIV/AIDS medications through patient assistance programs, welcomes Gilead Sciences as a participating company. Gilead joins Merck and ViiV Healthcare as the third pharmaceutical company to support HarborPath since its launch in July 2012.

"With Gilead's support of this pilot program, we can extend the reach of the organization and offer access to a broader-range of HIV/AIDS medications," said Ken Trogdon, Jr. , President of HarborPath. "We are thankful for the support of our pharmaceutical company partners and we urge others to join our efforts to serve individuals who need access to medications through patient assistance programs. These programs are a safety net for those who cannot afford their medications and they provide access to the life-saving drugs that allow people living with HIV/AIDS to live longer and healthier lives."

HarborPath is currently piloting the program in six states and Washington, D.C., having most recently added a clinic in South Carolina. HarborPath provides a streamlined process for healthcare professionals and case managers to connect individuals living with HIV/AIDS to multiple patient assistance programs using the common application form on the HarborPath website. The donated medications are delivered at no cost to qualified individuals through HarborPath's contracted mail-order pharmacy.  

"Access to medicines should never be a barrier to care, and I'm encouraged by HarborPath's efforts to ensure streamlined access to life-saving medications for people living with HIV/AIDS," said Congresswoman Barbara Lee of California, Co-Chair of the Congressional HIV/AIDS Caucus. "All stakeholders, including the government, private sector, faith communities, and the philanthropic community have an important role to play to ensure HIV/AIDS medications reach those who need them."

About HarborPath

HarborPath is a 501(c) (3) organization whose mission is to provide streamlined access to HIV/AIDS medications through patient assistance programs via an online portal. For more information, visit www.harborpath.org.


'/>"/>
SOURCE HarborPath
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. ePharmaSolutions Wins Major Award for Life Sciences Industry Innovation
2. USANA Health Sciences Now Offering Prenatal Product
3. Chipscreen Biosciences Announces Achievement of Primary Endpoint in Chidamide Registrational Trial in China
4. Ambit Biosciences Appoints David Parkinson, M.D., to Board of Directors
5. Antigen Laboratories, Inc. to be Acquired by Ares Life Sciences
6. Moravia Provides Guidance to Life Sciences Sector as Croatia Nears EU Accession and European Medicines Agency Deadlines Loom
7. Cleave Biosciences Adds New Investor and $10 Million to Series A Financing
8. GlaxoSmithKline and A*STARs Institute of Chemical Engineering and Sciences to Develop new Medicines for Emerging Markets
9. Xenon Named Life Sciences Company of the Year by LifeSciences British Columbia
10. VG Life Sciences Reports Positive Safety Results from Second Cohort Enrollment in Solid Tumor Clinical Trial
11. Neurocrine Biosciences Announces the Start of Phase IIb Study of Elagolix in Uterine Fibroids
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 Research and ... News Issue 52" report to their offering. ... influenza treatment creates a favourable commercial environment for MedImmune to ... patient base that will serve to drive considerable growth for ... would serve to cap sales considerably, but development is still ...
(Date:6/23/2016)... NORTHBROOK, Ill. and BOGOTA, Colombia , June 23, 2016  Astellas today announced the ... joins Astellas Farma Brasil as the company,s second affiliate in Latin America . ... ... appointed General Manager of Astellas Farma Colombia ... ...
(Date:6/23/2016)... Research and Markets has announced ... Analysis (United States, China, Japan, Brazil, United Kingdom, Germany, ... offering. Surgical Procedure ... planners, provides surgical procedure volume data in a geographic ... in-depth analysis of growth drivers and inhibitors, including world ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... people are unfamiliar with. The article goes on to state that individuals are now ... of these less common operations such as calf and cheek reduction. The Los Angeles ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, ... at his family verbally and physically. , “When something upset him, he couldn’t control his ... it. He would throw rocks at my other children and say he was going to ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas ... , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening their pencils ... an essay contest in which patients and their families pay tribute to a genetic ... 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® ... Group (TGIG), has initiated cultivation and processing operations at its production facility, and ... Nevada. , Puradigm is the manufacturer of a complete system of proactive air ...
Breaking Medicine News(10 mins):